Key result
Multicomponent intervention yields ~24.3-fold higher odds of appropriate inpatient statin prescribing.
Why the study?
Evidence on multicomponent programmes addressing statin prescribing appropriateness among Vietnamese inpatients remains limited.
Does a multicomponent educational and decision-support intervention improve appropriate statin prescribing among hospitalised adults in Vietnam?
Does a multicomponent educational and decision-support intervention improve appropriate statin prescribing among hospitalised adults in Vietnam?
Answers are grounded in this paper and cite their sources.
Implementation of a multicomponent intervention including physician education, risk tools, lab report LDL-C targets, and pharmacist-physician discussions was strongly associated with increased appropriate inpatient statin prescribing in a Vietnamese hospital.
Evidence on multicomponent programmes addressing statin prescribing among Vietnamese inpatients remains limited. This study evaluated the association between implementation of a multicomponent intervention and study-defined statin prescribing appropriateness, and identified factors associated with this outcome among hospitalised adults. This single-centre, uncontrolled before-and-after quasi-experimental study retrospectively reviewed 1,063 medical records of patients aged 20 years or older admitted to the Internal Medicine Department of Hoan My Dong Nai Hospital. The sample comprised 480 pre-intervention and 583 post-intervention patients. The multicomponent intervention comprised guideline education for physicians; cardiovascular risk-stratification and statin-intensity reference tools; display of risk-category-specific low-density lipoprotein cholesterol (LDL-C) targets on laboratory reports; and patient-specific pharmacist–physician discussions during ward rounds. The primary outcome was study-defined statin prescribing appropriateness according to the study’s indication-and-intensity criteria, assessed using the prescription on the last inpatient day before discharge. Appropriate prescribing increased from 8.1% to 61.6% (absolute difference, 53.5 percentage points; 95% CI: 48.6–57.9; p<0.001); among patients with atherosclerotic cardiovascular disease (ASCVD), it increased from 8.5% to 76.3%, and among those without ASCVD, from 7.7% to 48.2%. In the primary multivariable model including all 1,063 patients, the post-implementation period was associated with higher odds of appropriate prescribing (adjusted odds ratio=24.346; 95% confidence interval: 16.381–36.184; p<0.001). ASCVD was positively associated with the outcome, whereas patients aged 60–74 years and those aged ≥75 years had lower adjusted odds than patients aged <60 years; higher LDL-C was positively associated only in the supplementary model. The post-implementation period was associated with higher prescribing appropriateness; the uncontrolled design does not establish a causal effect of the multicomponent programme or any individual component.
No takes yet. Share an insight, caveat, or question.
Phát et al. (2026) studied Hospitalized adults evaluated for statin prescribing appropriateness (n=1,063). Multicomponent intervention (physician guideline education, cardiovascular risk-stratification and statin-intensity reference tools, LDL-C targets on lab reports, and ward round pharmacist-physician discussions) vs. Pre-intervention period (standard care) was evaluated on Study-defined statin prescribing appropriateness according to indication-and-intensity criteria on the last inpatient day before discharge (OR 24.346, 95% CI 16.381-36.184, p=<0.001). A multicomponent intervention increased appropriate inpatient statin prescribing from 8.1% to 61.6%.
Synapse has enriched 10 related papers. Consider them for comparative context: